I hope this email will find you in good health. I am writing to you about the introduction of fresh policies and actions needed to assist address specific CVID illness management in senior patients at Vila Health Hospital. Carl’s unique and crucial medical issue was covered in my earlier position paper with the aim of improving the organization’s quality outcomes and the well-being of the targeted disadvantaged group. This study will offer data that is based on evidence to examine the current state of policy recommendations and results, and also provide reasons for creating such a system to help the underprivileged population. The Food and Drug Administration classifies CVID in older adults aged 50 to 70 as a dangerous disease. This happens as a result of a lack of antibodies, but important experts and medical professionals still need to study and investigate its clinical importance. It occurs as a result of the varying immuno-deficiency phenomenon such that the patient Carl requires a new policy that will allow our nurses and clinicians to better treat the target medical concern (O’Farrill et al., 2017). This study will help determine whether the patient’s health is being negatively impacted by the current performance (Yakaboski et al., 2020).
Since we found that a genetic abnormality has a crucial role in the formation of CVID, it affects genes with lower body levels of IgG and leads to issues. It produces a persistent cough, ear problems, and diarrhea. The finest interventions and therapies recommended in the previously established policy show that a prevention strategy is always a successful method of preventing sickness in the first place. This indicates that the condition can quickly and easily spread from a family member who has it and can linger throughout a person’s lifetime. It is very difficult to prevent this genetic disease, and people who have a family history of CVID almost surely have a high chance of passing it on to the next generation. In order to reduce the incidence of CVID, the best course of action is to seek medical help right away after seeing symptoms in senior people.
Furthermore, according to the Yakaboski et al, (2020) study, avoiding CVID becomes quite challenging because clinicians are frequently unable to accurately identify what produces these genetic abnormalities in patients in the first place. Yet, in the instance of Carl, the family record reveals no evidence of CVID disease, making it difficult for doctors to determine the true cause and assist the patient in preventing it from spreading to other family members. Additionally, there is a lot of ambiguity in the most recent studies. Yazdani et al. (2020) claim that there are no effective treatments for CVID illness. However, specialists might advise continuing treatment to help many individuals get back to an active and healthy lifestyle. CVID can be fatal if the individual refuses to obey the nurses’ instructions, and it may take weeks of therapy to make the body recover. As a consequence, the current standard of care shows that it helped manage the patient’s chronic infections. The patient’s health has improved thanks to the antimicrobial’s therapies. The patient’s recovery from severe hepatitis, granulomas and other potential risks also shows the effectiveness of current programs.